These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 15123520

  • 1. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Keidar S, Kaplan M, Pavlotzky E, Coleman R, Hayek T, Hamoud S, Aviram M.
    Circulation; 2004 May 11; 109(18):2213-20. PubMed ID: 15123520
    [Abstract] [Full Text] [Related]

  • 2. Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients.
    Keidar S, Gamliel-Lazarovich A, Kaplan M, Pavlotzky E, Hamoud S, Hayek T, Karry R, Abassi Z.
    Circ Res; 2005 Oct 28; 97(9):946-53. PubMed ID: 16179584
    [Abstract] [Full Text] [Related]

  • 3. Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice.
    Keidar S, Hayek T, Kaplan M, Pavlotzky E, Hamoud S, Coleman R, Aviram M.
    J Cardiovasc Pharmacol; 2003 Jun 28; 41(6):955-63. PubMed ID: 12775976
    [Abstract] [Full Text] [Related]

  • 4. Mineralocorticoid receptor blockade inhibits accelerated atherosclerosis induced by a low sodium diet in apolipoprotein E-deficient mice.
    Raz-Pasteur A, Gamliel-Lazarovich A, Gantman A, Coleman R, Keidar S.
    J Renin Angiotensin Aldosterone Syst; 2014 Sep 28; 15(3):228-35. PubMed ID: 23223089
    [Abstract] [Full Text] [Related]

  • 5. Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation.
    Suzuki J, Iwai M, Mogi M, Oshita A, Yoshii T, Higaki J, Horiuchi M.
    Arterioscler Thromb Vasc Biol; 2006 Apr 28; 26(4):917-21. PubMed ID: 16424347
    [Abstract] [Full Text] [Related]

  • 6. Eplerenone reduced lesion size in early but not advanced atherosclerosis in apolipoprotein E-deficient mice.
    Raz-Pasteur A, Gamliel-Lazarovich A, Coleman R, Keidar S.
    J Cardiovasc Pharmacol; 2012 Dec 28; 60(6):508-12. PubMed ID: 23232789
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Noda K, Kobara M, Hamada J, Yoshifuji Y, Shiraishi T, Tanaka T, Wang J, Toba H, Nakata T.
    J Cardiovasc Pharmacol; 2012 Aug 28; 60(2):140-9. PubMed ID: 22549451
    [Abstract] [Full Text] [Related]

  • 9. Oxidative stress increases the expression of the angiotensin-II receptor type 1 in mouse peritoneal macrophages.
    Keidar S, Heinrich R, Kaplan M, Aviram M.
    J Renin Angiotensin Aldosterone Syst; 2002 Mar 28; 3(1):24-30. PubMed ID: 11984744
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
    Rozenberg O, Rosenblat M, Coleman R, Shih DM, Aviram M.
    Free Radic Biol Med; 2003 Mar 15; 34(6):774-84. PubMed ID: 12633754
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
    Bro S, Binder CJ, Witztum JL, Olgaard K, Nielsen LB.
    Arterioscler Thromb Vasc Biol; 2007 May 15; 27(5):1080-6. PubMed ID: 17347482
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis.
    Keidar S, Attias J, Heinrich R, Coleman R, Aviram M.
    Atherosclerosis; 1999 Oct 15; 146(2):249-57. PubMed ID: 10532681
    [Abstract] [Full Text] [Related]

  • 15. Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis.
    Hayek T, Kaplan M, Raz A, Keidar S, Coleman R, Aviram M.
    Atherosclerosis; 2002 Mar 15; 161(1):65-74. PubMed ID: 11882318
    [Abstract] [Full Text] [Related]

  • 16. The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.
    Hayek T, Attias J, Coleman R, Brodsky S, Smith J, Breslow JL, Keidar S.
    Cardiovasc Res; 1999 Dec 15; 44(3):579-87. PubMed ID: 10690290
    [Abstract] [Full Text] [Related]

  • 17. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y, Zhu A, Yoneda T, Usukura M, Takata H, Yamagishi M.
    Am J Hypertens; 2007 Oct 15; 20(10):1119-24. PubMed ID: 17903697
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
    Minas JN, Thorwald MA, Conte D, Vázquez-Medina JP, Nishiyama A, Ortiz RM.
    Clin Exp Pharmacol Physiol; 2015 Nov 15; 42(11):1178-88. PubMed ID: 26234762
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system.
    Hirono Y, Yoshimoto T, Suzuki N, Sugiyama T, Sakurada M, Takai S, Kobayashi N, Shichiri M, Hirata Y.
    Endocrinology; 2007 Apr 15; 148(4):1688-96. PubMed ID: 17218415
    [Abstract] [Full Text] [Related]

  • 20. Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats.
    Tada Y, Kitazato KT, Tamura T, Yagi K, Shimada K, Kinouchi T, Satomi J, Nagahiro S.
    Hypertension; 2009 Sep 15; 54(3):552-7. PubMed ID: 19620512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.